wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33265964-3B6E2356-FFE1-4718-8715-BEE1FD3B7F3B
Q33265964-3B6E2356-FFE1-4718-8715-BEE1FD3B7F3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33265964-3B6E2356-FFE1-4718-8715-BEE1FD3B7F3B
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.
P2860
Q33265964-3B6E2356-FFE1-4718-8715-BEE1FD3B7F3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33265964-3B6E2356-FFE1-4718-8715-BEE1FD3B7F3B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
015866936cc7add05558cbae4b445eb86d8215be
P2860
Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma.